| Code | CSB-RA011875MB1HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is developed as a research-grade biosimilar to Cytolin, targeting ITGAL (Integrin Subunit Alpha L), also known as CD11a or LFA-1 alpha chain. ITGAL forms part of the lymphocyte function-associated antigen-1 (LFA-1) heterodimer, a critical integrin expressed on leukocytes that mediates cell-cell interactions through binding to ICAM-1, ICAM-2, and ICAM-3. This interaction is essential for leukocyte adhesion, migration, and immune synapse formation during T cell activation. ITGAL plays a significant role in inflammatory responses and immune cell trafficking, making it relevant to autoimmune diseases, transplant rejection, and various inflammatory conditions including psoriasis and multiple sclerosis.
The reference antibody Cytolin has been utilized in immunological research to investigate LFA-1-mediated adhesion mechanisms and T cell function. This biosimilar antibody provides researchers with a reliable tool for studying ITGAL-dependent cellular processes, immune cell interactions, and the molecular basis of leukocyte migration. It supports investigations into therapeutic strategies targeting integrin-mediated pathways in immune-related disorders and cancer immunology.
There are currently no reviews for this product.